What is the recommended treatment for orthostatic tremor?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Orthostatic Tremor

Clonazepam and gabapentin are the first-line pharmacological treatments for orthostatic tremor, with gabapentin showing 60-80% improvement in patients and being effective even in those who failed clonazepam therapy. 1, 2, 3

Understanding Orthostatic Tremor

  • Orthostatic tremor is characterized by unsteadiness on standing due to a high-frequency tremor (13-18 Hz) involving the legs, which rapidly improves upon sitting or walking 2
  • Symptoms typically begin in the sixth decade of life and can significantly impact quality of life due to the strong need to sit down or move to avoid standing still 2
  • Diagnosis requires polygraphic recording confirming a fast and synchronous tremor of the legs between 13-18 Hz 2
  • The pathophysiology involves a ponto-cerebello-thalamo-cortical network, though the exact dysfunction remains incompletely understood 3

First-Line Pharmacological Treatment Options

  • Gabapentin is highly effective for orthostatic tremor with reported improvement of 60-80% (mean 73%) at doses ranging from 300-1800 mg/day (mean 1030 mg/day) 1
  • Clonazepam is widely used as a first-line agent, though efficacy may be inconsistent and some patients fail to respond 2, 3
  • Lower starting doses and more gradual titration of gabapentin may reduce adverse effects, especially in older individuals 4

Second-Line and Alternative Treatment Options

  • Dopaminergic medications may be helpful in some patients with orthostatic tremor, particularly those with concurrent Parkinson's disease 4
  • Perampanel, a novel AMPA receptor antagonist, has shown promising results with one case reporting 90% subjective improvement at doses of 1-2 mg/day 5
  • For medication-refractory cases, deep brain stimulation of the ventral intermediate nucleus of the thalamus has shown promise 3

Treatment Algorithm

  1. Start with either gabapentin (initial dose 300 mg/day, gradually titrate to 300-1800 mg/day based on response) or clonazepam 1, 2
  2. If the initial medication is ineffective or poorly tolerated, switch to the alternative first-line agent 3
  3. For partial response, consider combination therapy with both gabapentin and clonazepam 3
  4. For patients with inadequate response to first-line treatments, consider:
    • Dopaminergic medications, especially if Parkinson's features are present 4, 2
    • Trial of perampanel (starting at 1 mg/day) 5
    • Referral for deep brain stimulation evaluation in medication-refractory cases 3

Important Clinical Considerations

  • Distinguish orthostatic tremor from orthostatic hypotension, which requires different management approaches 4
  • Side effects of gabapentin are generally mild, transient, and dose-related 1
  • Treatment benefit for orthostatic tremor is often modest and inconsistent across patients, requiring trials of different medications 3
  • The response to treatment is often disappointing compared to other movement disorders, highlighting the need for individualized medication trials 2

References

Research

Effective treatment of orthostatic tremor with gabapentin.

Movement disorders : official journal of the Movement Disorder Society, 1998

Research

Orthostatic tremor - a review.

Handbook of clinical neurology, 2011

Research

Orthostatic Tremor: Pathophysiology Guiding Treatment.

Current treatment options in neurology, 2018

Guideline

Treatment of Orthostatic Tremor with Dopaminergic Medications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Successful Treatment of Primary Orthostatic Tremor Using Perampanel.

Tremor and other hyperkinetic movements (New York, N.Y.), 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.